TY  - CONF

T1  - Cost effectiveness of adalimumab therapy vs. conventional care in the United Kingdom (UK) patients with active ankylosing spondylitis (AS)

JO  - ANNALS OF THE RHEUMATIC DISEASES

PY  - 2006/07/01

AU  - Botteman MF

AU  - Hay JW

AU  - Van Hout BA

AU  - Curry A

AU  - Wong R

AU  - Luo MP

ED  - 

VL  - 65

SP  - 207

EP  - 208

Y2  - 2024/12/22

ER  -